Toppgene analysis for Wikipedia protein communities, toppgene analysis, cc256_10, positive side

Go To Start Page
Input Parameters [Show Detail]
Training Results [Expand All] [Download All] [Sparse Matrix]
Display pValues and Scores as Table row limit

1: GO: Molecular Function [Display Chart] 10 input genes in category / 21 annotations before applied cutoff / 18661 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 GO:0008236 serine-type peptidase activity 8.991E-10 1.017E-8 3.706E-8 1.888E-8 6 242
2 GO:0017171 serine hydrolase activity 9.683E-10 1.017E-8 3.706E-8 2.033E-8 6 245
3 GO:0004252 serine-type endopeptidase activity 4.660E-8 3.262E-7 1.189E-6 9.785E-7 5 215
4 GO:0004175 endopeptidase activity 1.962E-6 1.030E-5 3.755E-5 4.121E-5 5 457
5 GO:0004668 protein-arginine deiminase activity 2.582E-6 1.085E-5 3.954E-5 5.423E-5 2 5
6 GO:0016813 hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines 1.418E-5 4.963E-5 1.809E-4 2.978E-4 2 11
7 GO:0016810 hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds 2.697E-3 8.090E-3 2.949E-2
5.663E-2
 2 148
8 GO:0008239 dipeptidyl-peptidase activity 6.946E-3 1.745E-2
6.361E-2
1.459E-1
 1 13
9 GO:0004185 serine-type carboxypeptidase activity 7.479E-3 1.745E-2
6.361E-2
1.571E-1
 1 14
10 GO:0070008 serine-type exopeptidase activity 1.014E-2 2.129E-2
7.761E-2
2.129E-1
 1 19
11 GO:0004180 carboxypeptidase activity 2.176E-2 4.084E-2
1.489E-1
4.570E-1
 1 41
12 GO:0004177 aminopeptidase activity 2.334E-2 4.084E-2
1.489E-1
4.900E-1
 1 44
Show 7 more annotations

2: GO: Biological Process [Display Chart] 10 input genes in category / 157 annotations before applied cutoff / 18623 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 GO:0002786 regulation of antibacterial peptide production 3.898E-9 2.936E-7 1.655E-6 6.120E-7 3 7
2 GO:0002784 regulation of antimicrobial peptide production 3.898E-9 2.936E-7 1.655E-6 6.120E-7 3 7
3 GO:0002775 antimicrobial peptide production 9.350E-9 2.936E-7 1.655E-6 1.468E-6 3 9
4 GO:0002778 antibacterial peptide production 9.350E-9 2.936E-7 1.655E-6 1.468E-6 3 9
5 GO:0002759 regulation of antimicrobial humoral response 9.350E-9 2.936E-7 1.655E-6 1.468E-6 3 9
6 GO:1900424 regulation of defense response to bacterium 4.046E-8 1.059E-6 5.967E-6 6.352E-6 3 14
7 GO:0045745 positive regulation of G protein-coupled receptor signaling pathway 3.239E-7 7.265E-6 4.095E-5 5.086E-5 3 27
8 GO:0018101 protein citrullination 2.593E-6 5.087E-5 2.867E-4 4.071E-4 2 5
9 GO:0019731 antibacterial humoral response 3.045E-6 5.087E-5 2.867E-4 4.780E-4 3 56
10 GO:0002920 regulation of humoral immune response 3.387E-6 5.087E-5 2.867E-4 5.318E-4 3 58
11 GO:0002225 positive regulation of antimicrobial peptide production 3.888E-6 5.087E-5 2.867E-4 6.105E-4 2 6
12 GO:0002803 positive regulation of antibacterial peptide production 3.888E-6 5.087E-5 2.867E-4 6.105E-4 2 6
13 GO:0019730 antimicrobial humoral response 4.353E-6 5.257E-5 2.963E-4 6.835E-4 3 63
14 GO:0002760 positive regulation of antimicrobial humoral response 5.442E-6 6.103E-5 3.440E-4 8.544E-4 2 7
15 GO:0019240 citrulline biosynthetic process 1.165E-5 1.143E-4 6.444E-4 1.829E-3 2 10
16 GO:1900426 positive regulation of defense response to bacterium 1.165E-5 1.143E-4 6.444E-4 1.829E-3 2 10
17 GO:0008544 epidermis development 2.102E-5 1.941E-4 1.094E-3 3.299E-3 4 340
18 GO:0000052 citrulline metabolic process 2.354E-5 2.053E-4 1.157E-3 3.695E-3 2 14
19 GO:0002700 regulation of production of molecular mediator of immune response 2.737E-5 2.262E-4 1.275E-3 4.297E-3 3 116
20 GO:0002922 positive regulation of humoral immune response 4.416E-5 3.212E-4 1.810E-3 6.933E-3 2 19
21 GO:0018195 peptidyl-arginine modification 4.416E-5 3.212E-4 1.810E-3 6.933E-3 2 19
22 GO:0008277 regulation of G protein-coupled receptor signaling pathway 4.500E-5 3.212E-4 1.810E-3 7.066E-3 3 137
23 GO:0002440 production of molecular mediator of immune response 9.971E-5 6.806E-4 3.837E-3 1.565E-2 3 179
24 GO:0006959 humoral immune response 1.910E-4 1.250E-3 7.044E-3 2.999E-2 3 223
25 GO:0002833 positive regulation of response to biotic stimulus 2.889E-4 1.752E-3 9.876E-3 4.536E-2 2 48
26 GO:0002831 regulation of response to biotic stimulus 2.901E-4 1.752E-3 9.876E-3 4.555E-2 3 257
27 GO:0042742 defense response to bacterium 3.427E-4 1.993E-3 1.123E-2
5.381E-2
 3 272
28 GO:0042398 cellular modified amino acid biosynthetic process 4.368E-4 2.449E-3 1.381E-2
6.858E-2
 2 59
29 GO:0002787 negative regulation of antibacterial peptide production 5.370E-4 2.635E-3 1.485E-2
8.430E-2
 1 1
30 GO:0070684 seminal clot liquefaction 5.370E-4 2.635E-3 1.485E-2
8.430E-2
 1 1
31 GO:0002785 negative regulation of antimicrobial peptide production 5.370E-4 2.635E-3 1.485E-2
8.430E-2
 1 1
32 GO:0008348 negative regulation of antimicrobial humoral response 5.370E-4 2.635E-3 1.485E-2
8.430E-2
 1 1
33 GO:0002702 positive regulation of production of molecular mediator of immune response 6.866E-4 3.267E-3 1.841E-2
1.078E-1
 2 74
34 GO:0030198 extracellular matrix organization 7.400E-4 3.347E-3 1.887E-2
1.162E-1
 3 354
35 GO:0043062 extracellular structure organization 7.461E-4 3.347E-3 1.887E-2
1.171E-1
 3 355
36 GO:1901607 alpha-amino acid biosynthetic process 8.423E-4 3.673E-3 2.071E-2
1.322E-1
 2 82
37 GO:0022617 extracellular matrix disassembly 1.059E-3 4.492E-3 2.532E-2
1.662E-1
 2 92
38 GO:0008652 cellular amino acid biosynthetic process 1.176E-3 4.858E-3 2.738E-2
1.846E-1
 2 97
39 GO:0002353 plasma kallikrein-kinin cascade 1.610E-3 6.274E-3 3.537E-2
2.528E-1
 1 3
40 GO:1900425 negative regulation of defense response to bacterium 1.610E-3 6.274E-3 3.537E-2
2.528E-1
 1 3
41 GO:0002697 regulation of immune effector process 1.638E-3 6.274E-3 3.537E-2
2.572E-1
 3 466
42 GO:0002254 kinin cascade 2.146E-3 8.023E-3 4.522E-2
3.370E-1
 1 4
43 GO:0002155 regulation of thyroid hormone mediated signaling pathway 2.682E-3 9.793E-3
5.520E-2
4.211E-1
 1 5
44 GO:0002154 thyroid hormone mediated signaling pathway 3.218E-3 1.148E-2
6.472E-2
5.052E-1
 1 6
45 GO:0043902 positive regulation of multi-organism process 3.471E-3 1.211E-2
6.827E-2
5.450E-1
 2 168
46 GO:0002699 positive regulation of immune effector process 4.191E-3 1.431E-2
8.063E-2
6.580E-1
 2 185
47 GO:1902572 negative regulation of serine-type peptidase activity 5.892E-3 1.927E-2
1.086E-1
9.251E-1
 1 11
48 GO:1900004 negative regulation of serine-type endopeptidase activity 5.892E-3 1.927E-2
1.086E-1
9.251E-1
 1 11
49 GO:0042640 anagen 6.427E-3 2.059E-2
1.161E-1
1.000E0
 1 12
50 GO:0016540 protein autoprocessing 6.960E-3 2.102E-2
1.185E-1
1.000E0
 1 13
Show 45 more annotations

3: GO: Cellular Component [Display Chart] 10 input genes in category / 12 annotations before applied cutoff / 19061 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 GO:0097209 epidermal lamellar body 4.158E-10 4.990E-9 1.548E-8 4.990E-9 3 4
2 GO:0042599 lamellar body 1.180E-7 7.079E-7 2.197E-6 1.416E-6 3 20
3 GO:0030141 secretory granule 9.863E-4 3.945E-3 1.224E-2 1.184E-2 3 400
4 GO:0030057 desmosome 1.356E-2 4.068E-2
1.262E-1
1.627E-1
 1 26
5 GO:0005921 gap junction 1.770E-2 4.248E-2
1.318E-1
2.124E-1
 1 34
6 GO:0045171 intercellular bridge 2.285E-2 4.570E-2
1.418E-1
2.742E-1
 1 44
Show 1 more annotation

4: Human Phenotype [Display Chart] 2 input genes in category / 96 annotations before applied cutoff / 4707 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 HP:0003328 Abnormal hair laboratory examination 3.928E-5 3.770E-3 1.941E-2 3.770E-3 2 30
2 HP:0002552 Trichodysplasia 8.497E-4 4.076E-2
2.098E-1
8.157E-2
 1 2
3 HP:0004906 Hypernatremic dehydration 1.274E-3 4.076E-2
2.098E-1
1.223E-1
 1 3
4 HP:0030056 Uncombable hair 1.699E-3 4.076E-2
2.098E-1
1.631E-1
 1 4
5 HP:0001986 Hypertonic dehydration 2.124E-3 4.076E-2
2.098E-1
2.039E-1
 1 5
6 HP:0010719 Abnormality of hair texture 2.655E-3 4.076E-2
2.098E-1
2.549E-1
 2 243
7 HP:0002235 Pili canaliculi 2.972E-3 4.076E-2
2.098E-1
2.854E-1
 1 7
8 HP:0100665 Angioedema 3.397E-3 4.076E-2
2.098E-1
3.261E-1
 1 8
9 HP:0003193 Allergic rhinitis 4.245E-3 4.482E-2
2.307E-1
4.075E-1
 1 10
10 HP:0009886 Trichorrhexis nodosa 4.669E-3 4.482E-2
2.307E-1
4.482E-1
 1 11
Show 5 more annotations

5: Mouse Phenotype [Display Chart] 8 input genes in category / 112 annotations before applied cutoff / 10355 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 MP:0001195 flaky skin 1.429E-4 1.601E-2
8.485E-2
 1.601E-2 2 24
2 MP:0003427 parakeratosis 3.068E-4 1.718E-2
9.107E-2
 3.437E-2 2 35
3 MP:0010700 hair follicle comedo 7.726E-4 1.731E-2
9.172E-2
8.653E-2
 1 1
4 MP:0009291 decreased femoral fat pad weight 7.726E-4 1.731E-2
9.172E-2
8.653E-2
 1 1
5 MP:0008905 abnormal femoral fat pad morphology 7.726E-4 1.731E-2
9.172E-2
8.653E-2
 1 1
6 MP:0030572 abnormal pilosebaceous unit morphology 1.187E-3 2.215E-2
1.174E-1
1.329E-1
 3 298
7 MP:0001236 abnormal epidermis stratum spinosum morphology 1.523E-3 2.437E-2
1.292E-1
1.706E-1
 2 78
8 MP:0002796 impaired skin barrier function 2.066E-3 2.684E-2
1.423E-1
2.314E-1
 2 91
9 MP:0003809 abnormal hair shaft morphology 2.157E-3 2.684E-2
1.423E-1
2.416E-1
 2 93
10 MP:0004241 acantholysis 3.087E-3 3.458E-2
1.833E-1
3.458E-1
 1 4
11 MP:0001242 hyperkeratosis 3.920E-3 3.498E-2
1.854E-1
4.391E-1
 2 126
12 MP:0002098 abnormal vibrissa morphology 4.043E-3 3.498E-2
1.854E-1
4.528E-1
 2 128
13 MP:0030533 abnormal snout skin morphology 4.628E-3 3.498E-2
1.854E-1
5.183E-1
 1 6
14 MP:0001283 sparse vibrissae 4.628E-3 3.498E-2
1.854E-1
5.183E-1
 1 6
15 MP:0001212 skin lesions 4.684E-3 3.498E-2
1.854E-1
5.246E-1
 2 138
16 MP:0002832 coarse hair 5.397E-3 3.556E-2
1.885E-1
6.045E-1
 1 7
17 MP:0001230 epidermal desquamation 5.397E-3 3.556E-2
1.885E-1
6.045E-1
 1 7
18 MP:0001240 abnormal epidermis stratum corneum morphology 6.950E-3 4.325E-2
2.292E-1
7.785E-1
 2 169
19 MP:0001247 dermal cysts 7.702E-3 4.540E-2
2.406E-1
8.627E-1
 1 10
Show 14 more annotations

6: Domain [Display Chart] 10 input genes in category / 44 annotations before applied cutoff / 18735 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 IPR033116 TRYPSIN SER InterPro 5.653E-10 1.214E-8 5.308E-8 2.487E-8 5 90
2 IPR018114 TRYPSIN HIS InterPro 1.123E-9 1.214E-8 5.308E-8 4.940E-8 5 103
3 PS00135 TRYPSIN SER PROSITE 1.299E-9 1.214E-8 5.308E-8 5.715E-8 5 106
4 PS00134 TRYPSIN HIS PROSITE 1.362E-9 1.214E-8 5.308E-8 5.994E-8 5 107
5 IPR001314 Peptidase S1A InterPro 1.796E-9 1.214E-8 5.308E-8 7.903E-8 5 113
6 PS50240 TRYPSIN DOM PROSITE 1.963E-9 1.214E-8 5.308E-8 8.637E-8 5 115
7 SM00020 Tryp SPc SMART 2.142E-9 1.214E-8 5.308E-8 9.425E-8 5 117
8 IPR001254 Trypsin dom InterPro 2.539E-9 1.214E-8 5.308E-8 1.117E-7 5 121
9 PF00089 Trypsin Pfam 2.539E-9 1.214E-8 5.308E-8 1.117E-7 5 121
10 IPR009003 Peptidase S1 PA InterPro 2.759E-9 1.214E-8 5.308E-8 1.214E-7 5 123
11 PF08527 PAD M Pfam 2.562E-6 6.631E-6 2.900E-5 1.127E-4 2 5
12 IPR013530 PAD C InterPro 2.562E-6 6.631E-6 2.900E-5 1.127E-4 2 5
13 IPR013733 Prot Arg deaminase cen dom InterPro 2.562E-6 6.631E-6 2.900E-5 1.127E-4 2 5
14 PF08526 PAD N Pfam 2.562E-6 6.631E-6 2.900E-5 1.127E-4 2 5
15 PF03068 PAD Pfam 2.562E-6 6.631E-6 2.900E-5 1.127E-4 2 5
16 IPR004303 PAD InterPro 2.562E-6 6.631E-6 2.900E-5 1.127E-4 2 5
17 IPR013732 PAD N InterPro 2.562E-6 6.631E-6 2.900E-5 1.127E-4 2 5
18 IPR008972 Cupredoxin InterPro 5.890E-5 1.440E-4 6.295E-4 2.591E-3 2 22
19 PF05577 Peptidase S28 Pfam 1.601E-3 3.521E-3 1.540E-2
7.042E-2
 1 3
20 IPR008758 Peptidase S28 InterPro 1.601E-3 3.521E-3 1.540E-2
7.042E-2
 1 3
21 IPR009122 Desmosomal cadherin InterPro 3.731E-3 7.462E-3 3.263E-2
1.642E-1
 1 7
22 PF08758 Cadherin pro Pfam 3.731E-3 7.462E-3 3.263E-2
1.642E-1
 1 7
23 SM01055 Cadherin pro SMART 4.263E-3 7.815E-3 3.417E-2
1.876E-1
 1 8
24 IPR014868 Cadherin pro dom InterPro 4.263E-3 7.815E-3 3.417E-2
1.876E-1
 1 8
25 PS00282 KAZAL 1 PROSITE 9.569E-3 1.684E-2
7.364E-2
4.210E-1
 1 18
26 PF00050 Kazal 1 Pfam 1.168E-2 1.977E-2
8.646E-2
5.141E-1
 1 22
27 PF01049 Cadherin C Pfam 1.327E-2 2.085E-2
9.117E-2
5.838E-1
 1 25
28 IPR000233 Cadherin cytoplasmic-dom InterPro 1.327E-2 2.085E-2
9.117E-2
5.838E-1
 1 25
29 4.10.900.10 - Gene3D 1.538E-2 2.255E-2
9.861E-2
6.765E-1
 1 29
30 IPR027397 Catenin binding dom InterPro 1.538E-2 2.255E-2
9.861E-2
6.765E-1
 1 29
31 PF07648 Kazal 2 Pfam 1.905E-2 2.705E-2
1.183E-1
8.384E-1
 1 36
32 SM00280 KAZAL SMART 2.429E-2 3.340E-2
1.460E-1
1.000E0
 1 46
33 PS51465 KAZAL 2 PROSITE 2.638E-2 3.481E-2
1.522E-1
1.000E0
 1 50
34 IPR002350 Kazal dom InterPro 2.690E-2 3.481E-2
1.522E-1
1.000E0
 1 51
Show 29 more annotations

7: Pathway [Display Chart] 10 input genes in category / 22 annotations before applied cutoff / 12450 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 1457791 Formation of the cornified envelope BioSystems: REACTOME 1.987E-7 4.372E-6 1.613E-5 4.372E-6 4 71
2 142167 protein citrullination BioSystems: BIOCYC 3.481E-6 3.829E-5 1.413E-4 7.658E-5 2 4
3 1457790 Keratinization BioSystems: REACTOME 1.644E-5 1.205E-4 4.449E-4 3.616E-4 4 214
4 83075 Renin-angiotensin system BioSystems: KEGG 1.456E-4 8.008E-4 2.956E-3 3.203E-3 2 23
5 1270257 Degradation of the extracellular matrix BioSystems: REACTOME 3.443E-3 1.515E-2
5.592E-2
7.575E-2
 2 112
6 1268755 Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) BioSystems: REACTOME 1.675E-2 4.804E-2
1.773E-1
3.684E-1
 1 21
7 1269370 Intrinsic Pathway of Fibrin Clot Formation BioSystems: REACTOME 1.754E-2 4.804E-2
1.773E-1
3.858E-1
 1 22
8 1270433 Chromatin organization BioSystems: REACTOME 2.000E-2 4.804E-2
1.773E-1
4.399E-1
 2 279
9 1270434 Chromatin modifying enzymes BioSystems: REACTOME 2.000E-2 4.804E-2
1.773E-1
4.399E-1
 2 279
10 1270244 Extracellular matrix organization BioSystems: REACTOME 2.263E-2 4.804E-2
1.773E-1
4.979E-1
 2 298
11 137913 Alpha-synuclein signaling BioSystems: Pathway Interaction Database 2.542E-2 4.804E-2
1.773E-1
5.592E-1
 1 32
12 1270258 Activation of Matrix Metalloproteinases BioSystems: REACTOME 2.620E-2 4.804E-2
1.773E-1
5.764E-1
 1 33
Show 7 more annotations

8: Pubmed [Display Chart] 10 input genes in category / 514 annotations before applied cutoff / 38193 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 19558318 Association between kallikrein-related peptidases (KLKs) and macroscopic indicators of semen analysis: their relation to sperm motility. Pubmed 9.374E-17 4.818E-14 3.286E-13 4.818E-14 5 10
2 15203212 Taxon-specific evolution of glandular kallikrein genes and identification of a progenitor of prostate-specific antigen. Pubmed 7.444E-16 1.435E-13 9.785E-13 3.826E-13 5 14
3 16800723 Proceedings of the 1st International Symposium on Kallikreins, Lausanne, Switzerland, September 1-3 , 2005. Pubmed 1.116E-15 1.435E-13 9.785E-13 5.739E-13 5 15
4 16800724 A comprehensive nomenclature for serine proteases with homology to tissue kallikreins. Pubmed 1.116E-15 1.435E-13 9.785E-13 5.739E-13 5 15
5 20424135 Blood biomarker levels to aid discovery of cancer-related single-nucleotide polymorphisms: kallikreins and prostate cancer. Pubmed 1.624E-15 1.669E-13 1.139E-12 8.346E-13 5 16
6 15192120 Human tissue kallikreins: physiologic roles and applications in cancer. Pubmed 1.171E-12 8.602E-11 5.867E-10 6.021E-10 4 12
7 25666037 Differences in Kallikrein-related peptidase mRNA sequences and KLK6 enzyme activity between mouse strains. Pubmed 1.171E-12 8.602E-11 5.867E-10 6.021E-10 4 12
8 11054574 Sequencing and expression analysis of the serine protease gene cluster located in chromosome 19q13 region. Pubmed 4.305E-12 2.766E-10 1.887E-9 2.213E-9 4 16
9 15675955 LEKTI is localized in lamellar granules, separated from KLK5 and KLK7, and is secreted in the extracellular spaces of the superficial stratum granulosum. Pubmed 1.292E-11 6.039E-10 4.119E-9 6.643E-9 3 3
10 19118981 Dichotomous effect of ultraviolet B on the expression of corneodesmosomal enzymes in human epidermal keratinocytes. Pubmed 1.292E-11 6.039E-10 4.119E-9 6.643E-9 3 3
11 16885167 Proteinase-activated receptors, targets for kallikrein signaling. Pubmed 1.292E-11 6.039E-10 4.119E-9 6.643E-9 3 3
12 16628198 Corneodesmosomal cadherins are preferential targets of stratum corneum trypsin- and chymotrypsin-like hyperactivity in Netherton syndrome. Pubmed 5.169E-11 1.898E-9 1.294E-8 2.657E-8 3 4
13 17158887 A potential role for multiple tissue kallikrein serine proteases in epidermal desquamation. Pubmed 5.169E-11 1.898E-9 1.294E-8 2.657E-8 3 4
14 17012259 Kallikrein-mediated proteolysis regulates the antimicrobial effects of cathelicidins in skin. Pubmed 5.169E-11 1.898E-9 1.294E-8 2.657E-8 3 4
15 29229980 Molecular cloning of novel transcripts of human kallikrein-related peptidases 5, 6, 7, 8 and 9 (KLK5 - KLK9), using Next-generation sequencing. Pubmed 1.292E-10 4.428E-9 3.020E-8 6.641E-8 3 5
16 10969073 Tissue-specific expression patterns and fine mapping of the human kallikrein (KLK) locus on proximal 19q13.4. Pubmed 4.521E-10 1.452E-8 9.906E-8 2.324E-7 3 7
17 28095415 KLK5 and KLK7 Ablation Fully Rescues Lethality of Netherton Syndrome-Like Phenotype. Pubmed 2.840E-9 8.586E-8 5.856E-7 1.460E-6 3 12
18 21868565 Evaluation of kallikrein-related peptidase 5 expression and its significance for breast cancer patients: association with kallikrein-related peptidase 7 expression. Pubmed 6.170E-8 1.023E-6 6.977E-6 3.171E-5 2 2
19 25477184 Kallikrein family proteases KLK6 and KLK7 are potential early detection and diagnostic biomarkers for serous and papillary serous ovarian cancer subtypes. Pubmed 6.170E-8 1.023E-6 6.977E-6 3.171E-5 2 2
20 18163887 Tissue-specific promoter utilisation of the kallikrein-related peptidase genes, KLK5 and KLK7, and cellular localisation of the encoded proteins suggest roles in exocrine pancreatic function. Pubmed 6.170E-8 1.023E-6 6.977E-6 3.171E-5 2 2
21 15150696 Identification of 45 novel SNPs in the 83-kb region containing peptidylarginine deiminase types 1 and 3 loci on chromosomal band 1p36.13. Pubmed 6.170E-8 1.023E-6 6.977E-6 3.171E-5 2 2
22 15766562 KLK5 and KLK7, two members of the human tissue kallikrein family, are differentially expressed in lung cancer. Pubmed 6.170E-8 1.023E-6 6.977E-6 3.171E-5 2 2
23 12738725 Differential splicing of KLK5 and KLK7 in epithelial ovarian cancer produces novel variants with potential as cancer biomarkers. Pubmed 6.170E-8 1.023E-6 6.977E-6 3.171E-5 2 2
24 23224034 Parallel overexpression and clinical significance of kallikrein-related peptidases 7 and 14 (KLK7KLK14) in colon cancer. Pubmed 6.170E-8 1.023E-6 6.977E-6 3.171E-5 2 2
25 17625593 Activation of proteinase-activated receptor-2 by human kallikrein-related peptidases. Pubmed 6.170E-8 1.023E-6 6.977E-6 3.171E-5 2 2
26 26022646 The Co-Expression of Kallikrein 5 and Kallikrein 7 Associates with Poor Survival in Non-HPV Oral Squamous-Cell Carcinoma. Pubmed 6.170E-8 1.023E-6 6.977E-6 3.171E-5 2 2
27 16091842 The peptidylarginine deiminases expressed in human epidermis differ in their substrate specificities and subcellular locations. Pubmed 6.170E-8 1.023E-6 6.977E-6 3.171E-5 2 2
28 26390218 KLK5 Inactivation Reverses Cutaneous Hallmarks of Netherton Syndrome. Pubmed 6.170E-8 1.023E-6 6.977E-6 3.171E-5 2 2
29 27769847 Incomplete KLK7 Secretion and Upregulated LEKTI Expression Underlie Hyperkeratotic Stratum Corneum in Atopic Dermatitis. Pubmed 6.170E-8 1.023E-6 6.977E-6 3.171E-5 2 2
30 19453546 Parallel underexpression of kallikrein 5 and kallikrein 7 mRNA in breast malignancies. Pubmed 6.170E-8 1.023E-6 6.977E-6 3.171E-5 2 2
31 15654974 A proteolytic cascade of kallikreins in the stratum corneum. Pubmed 6.170E-8 1.023E-6 6.977E-6 3.171E-5 2 2
32 15466487 Epidermal detachment, desmosomal dissociation, and destabilization of corneodesmosin in Spink5-/- mice. Pubmed 1.851E-7 2.320E-6 1.582E-5 9.513E-5 2 3
33 22102857 Kallikreins 5, 6 and 10 differentially alter pathophysiology and overall survival in an ovarian cancer xenograft model. Pubmed 1.851E-7 2.320E-6 1.582E-5 9.513E-5 2 3
34 18774391 Analysis of the individual and aggregate genetic contributions of previously identified serine peptidase inhibitor Kazal type 5 (SPINK5), kallikrein-related peptidase 7 (KLK7), and filaggrin (FLG) polymorphisms to eczema risk. Pubmed 1.851E-7 2.320E-6 1.582E-5 9.513E-5 2 3
35 17989887 Analysis of SPINK 5, KLK 7 and FLG genotypes in a French atopic dermatitis cohort. Pubmed 1.851E-7 2.320E-6 1.582E-5 9.513E-5 2 3
36 15675958 Peptidylarginine deiminase isoforms 1-3 are expressed in the epidermis and involved in the deimination of K1 and filaggrin. Pubmed 1.851E-7 2.320E-6 1.582E-5 9.513E-5 2 3
37 1778991 Three types of mouse peptidylarginine deiminase: characterization and tissue distribution. Pubmed 1.851E-7 2.320E-6 1.582E-5 9.513E-5 2 3
38 26231762 Prognostic significance of multiple kallikreins in high-grade astrocytoma. Pubmed 1.851E-7 2.320E-6 1.582E-5 9.513E-5 2 3
39 16973334 Peptidylarginine deiminases and deimination in biology and pathology: relevance to skin homeostasis. Pubmed 1.851E-7 2.320E-6 1.582E-5 9.513E-5 2 3
40 20090765 Kallikrein expression and cathelicidin processing are independently controlled in keratinocytes by calcium, vitamin D(3), and retinoic acid. Pubmed 1.851E-7 2.320E-6 1.582E-5 9.513E-5 2 3
41 26616205 Acefylline activates filaggrin deimination by peptidylarginine deiminases in the upper epidermis. Pubmed 1.851E-7 2.320E-6 1.582E-5 9.513E-5 2 3
42 10092850 Molecular cloning of cDNAs of mouse peptidylarginine deiminase type I, type III and type IV, and the expression pattern of type I in mouse. Pubmed 3.701E-7 3.963E-6 2.703E-5 1.902E-4 2 4
43 21741862 Common variation in Kallikrein genes KLK5, KLK6, KLK12, and KLK13 and risk of prostate cancer and tumor aggressiveness. Pubmed 3.701E-7 3.963E-6 2.703E-5 1.902E-4 2 4
44 15140227 Degradation of corneodesmosome proteins by two serine proteases of the kallikrein family, SCTE/KLK5/hK5 and SCCE/KLK7/hK7. Pubmed 3.701E-7 3.963E-6 2.703E-5 1.902E-4 2 4
45 27929094 Peptidylarginine deiminase 1-catalyzed histone citrullination is essential for early embryo development. Pubmed 3.701E-7 3.963E-6 2.703E-5 1.902E-4 2 4
46 14579251 PAD, a growing family of citrullinating enzymes: genes, features and involvement in disease. Pubmed 3.701E-7 3.963E-6 2.703E-5 1.902E-4 2 4
47 19560453 The kallikrein family of proteins as urinary biomarkers for the detection of prostate cancer. Pubmed 3.701E-7 3.963E-6 2.703E-5 1.902E-4 2 4
48 19085836 Multiple kallikrein (KLK 5, 7, 8, and 10) expression in squamous cell carcinoma of the oral cavity. Pubmed 3.701E-7 3.963E-6 2.703E-5 1.902E-4 2 4
49 15087120 Comparative analysis of the mouse and human peptidylarginine deiminase gene clusters reveals highly conserved non-coding segments and a new human gene, PADI6. Pubmed 9.250E-7 9.703E-6 6.618E-5 4.754E-4 2 6
50 12437987 Organization and evolution of the glandular kallikrein locus in Mus musculus. Pubmed 1.726E-6 1.774E-5 1.210E-4 8.872E-4 2 8
Show 45 more annotations

9: Interaction [Display Chart] 9 input genes in category / 173 annotations before applied cutoff / 17703 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 int:PADI1 PADI1 interactions 2.296E-6 3.972E-4 2.277E-3 3.972E-4 2 5
2 int:PADI3 PADI3 interactions 3.112E-5 1.879E-3 1.077E-2 5.384E-3 2 17
3 int:SERPINC1 SERPINC1 interactions 3.500E-5 1.879E-3 1.077E-2 6.056E-3 2 18
4 int:SERPINF2 SERPINF2 interactions 4.345E-5 1.879E-3 1.077E-2 7.516E-3 2 20
5 int:DSG1 DSG1 interactions 3.488E-4 1.207E-2
6.920E-2
6.035E-2
 2 56
6 int:PI4KA PI4KA interactions 8.025E-4 2.271E-2
1.302E-1
1.388E-1
 2 85
7 int:BAG4 BAG4 interactions 9.190E-4 2.271E-2
1.302E-1
1.590E-1
 2 91
8 int:FTH1 FTH1 interactions 1.108E-3 2.397E-2
1.374E-1
1.917E-1
 2 100
9 int:FUK FUK interactions 2.032E-3 3.516E-2
2.016E-1
3.516E-1
 1 4
10 int:SPINK5 SPINK5 interactions 2.032E-3 3.516E-2
2.016E-1
3.516E-1
 1 4
11 int:NEU3 NEU3 interactions 3.554E-3 4.913E-2
2.817E-1
6.148E-1
 1 7
12 int:TSG101 TSG101 interactions 3.648E-3 4.913E-2
2.817E-1
6.310E-1
 2 183
13 int:PLCZ1 PLCZ1 interactions 4.061E-3 4.913E-2
2.817E-1
7.025E-1
 1 8
14 int:KIAA1147 KIAA1147 interactions 4.061E-3 4.913E-2
2.817E-1
7.025E-1
 1 8
15 int:IGFBP2 IGFBP2 interactions 5.074E-3 4.913E-2
2.817E-1
8.777E-1
 1 10
16 int:TUBB3 TUBB3 interactions 6.039E-3 4.913E-2
2.817E-1
1.000E0
 2 237
17 int:COX11 COX11 interactions 6.086E-3 4.913E-2
2.817E-1
1.000E0
 1 12
18 int:TGFB1 TGFB1 interactions 6.188E-3 4.913E-2
2.817E-1
1.000E0
 2 240
19 int:KLK6 KLK6 interactions 7.602E-3 4.913E-2
2.817E-1
1.000E0
 1 15
20 int:FBXO42 FBXO42 interactions 7.602E-3 4.913E-2
2.817E-1
1.000E0
 1 15
21 int:CDSN CDSN interactions 8.611E-3 4.913E-2
2.817E-1
1.000E0
 1 17
22 int:TRMT44 TRMT44 interactions 8.611E-3 4.913E-2
2.817E-1
1.000E0
 1 17
23 int:PADI4 PADI4 interactions 8.611E-3 4.913E-2
2.817E-1
1.000E0
 1 17
24 int:TUBA4A TUBA4A interactions 8.629E-3 4.913E-2
2.817E-1
1.000E0
 2 285
25 int:SERPINA4 SERPINA4 interactions 9.116E-3 4.913E-2
2.817E-1
1.000E0
 1 18
26 int:STAP2 STAP2 interactions 9.116E-3 4.913E-2
2.817E-1
1.000E0
 1 18
27 int:NUCKS1 NUCKS1 interactions 1.012E-2 4.913E-2
2.817E-1
1.000E0
 1 20
28 int:KLK2 KLK2 interactions 1.063E-2 4.913E-2
2.817E-1
1.000E0
 1 21
29 int:NAT2 NAT2 interactions 1.113E-2 4.913E-2
2.817E-1
1.000E0
 1 22
30 int:CERCAM CERCAM interactions 1.214E-2 4.913E-2
2.817E-1
1.000E0
 1 24
31 int:ARSA ARSA interactions 1.214E-2 4.913E-2
2.817E-1
1.000E0
 1 24
32 int:ADAMTS1 ADAMTS1 interactions 1.214E-2 4.913E-2
2.817E-1
1.000E0
 1 24
33 int:KIR3DS1 KIR3DS1 interactions 1.264E-2 4.913E-2
2.817E-1
1.000E0
 1 25
34 int:PNPO PNPO interactions 1.264E-2 4.913E-2
2.817E-1
1.000E0
 1 25
35 int:SERPINE1 SERPINE1 interactions 1.314E-2 4.913E-2
2.817E-1
1.000E0
 1 26
36 int:KLK7 KLK7 interactions 1.314E-2 4.913E-2
2.817E-1
1.000E0
 1 26
37 int:LOXL2 LOXL2 interactions 1.314E-2 4.913E-2
2.817E-1
1.000E0
 1 26
38 int:IL31RA IL31RA interactions 1.314E-2 4.913E-2
2.817E-1
1.000E0
 1 26
39 int:PAX2 PAX2 interactions 1.314E-2 4.913E-2
2.817E-1
1.000E0
 1 26
40 int:PRCP PRCP interactions 1.314E-2 4.913E-2
2.817E-1
1.000E0
 1 26
41 int:SERPINB6 SERPINB6 interactions 1.314E-2 4.913E-2
2.817E-1
1.000E0
 1 26
42 int:FREM2 FREM2 interactions 1.365E-2 4.913E-2
2.817E-1
1.000E0
 1 27
43 int:SERPINE2 SERPINE2 interactions 1.415E-2 4.913E-2
2.817E-1
1.000E0
 1 28
44 int:AGT AGT interactions 1.415E-2 4.913E-2
2.817E-1
1.000E0
 1 28
45 int:GLG1 GLG1 interactions 1.465E-2 4.913E-2
2.817E-1
1.000E0
 1 29
46 int:CELSR2 CELSR2 interactions 1.465E-2 4.913E-2
2.817E-1
1.000E0
 1 29
47 int:PRSS1 PRSS1 interactions 1.465E-2 4.913E-2
2.817E-1
1.000E0
 1 29
48 int:TEX35 TEX35 interactions 1.465E-2 4.913E-2
2.817E-1
1.000E0
 1 29
49 int:EME1 EME1 interactions 1.465E-2 4.913E-2
2.817E-1
1.000E0
 1 29
50 int:SEMG2 SEMG2 interactions 1.515E-2 4.913E-2
2.817E-1
1.000E0
 1 30
Show 45 more annotations

10: Cytoband [Display Chart] 10 input genes in category / 8 annotations before applied cutoff / 34661 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 1p36.13 1p36.13 1.689E-4 9.356E-4 2.543E-3 1.351E-3 2 68
2 19q13.41 19q13.41 2.339E-4 9.356E-4 2.543E-3 1.871E-3 2 80
3 11q14 11q14 3.457E-3 7.490E-3 2.036E-2 2.766E-2 1 12
4 19q13.3-q13.4 19q13.3-q13.4 3.745E-3 7.490E-3 2.036E-2 2.996E-2 1 13
5 18q12.1 18q12.1 8.336E-3 1.334E-2 3.625E-2
6.669E-2
 1 29
6 5q32 5q32 1.576E-2 2.101E-2
5.710E-2
1.261E-1
 1 55
7 19q13.3 19q13.3 2.398E-2 2.740E-2
7.447E-2
1.918E-1
 1 84
8 19q13.33 19q13.33 3.073E-2 3.073E-2
8.352E-2
2.458E-1
 1 108
Show 3 more annotations

11: Transcription Factor Binding Site [Display Chart] 10 input genes in category / 29 annotations before applied cutoff / 9770 genes in category

No results to display

12: Gene Family [Display Chart] 10 input genes in category / 7 annotations before applied cutoff / 18194 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 616 Kallikreins|Proteases, serine genenames.org 6.613E-14 4.629E-13 1.200E-12 4.629E-13 5 16
2 677 Peptidyl arginine deiminases genenames.org 2.717E-6 9.508E-6 2.465E-5 1.902E-5 2 5
3 738 Proteases, serine genenames.org 5.216E-4 1.217E-3 3.156E-3 3.651E-3 2 63
4 1188 Desmosomal cadherins genenames.org 3.842E-3 6.723E-3 1.743E-2 2.689E-2 1 7
5 740 Serine peptidase inhibitors, Kazal type genenames.org 5.484E-3 7.678E-3 1.991E-2 3.839E-2 1 10
6 1321 Carboxypeptidases genenames.org 1.149E-2 1.340E-2 3.474E-2
8.040E-2
 1 21
7 870 Minor histocompatibility antigens|FERM domain containing genenames.org 2.769E-2 2.769E-2
7.179E-2
1.938E-1
 1 51
Show 2 more annotations

13: Coexpression [Display Chart] 10 input genes in category / 601 annotations before applied cutoff / 23137 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 M16130 Cluster c: genes identifying an intrinsic group in head and neck squamous cell carcinoma (HNSCC). MSigDB C2: CGP Curated Gene Sets (v6.0) 1.068E-7 3.998E-5 2.789E-4 6.421E-5 4 112
2 M18213 Genes down-regulated in Barrett's esophagus compared to the normal tissue. MSigDB C2: CGP Curated Gene Sets (v6.0) 1.331E-7 3.998E-5 2.789E-4 7.997E-5 3 25
3 16449976-SuppTable1 Human Esophagus Wang06 82genes GeneSigDB 3.559E-6 7.130E-4 4.974E-3 2.139E-3 3 73
4 20940404-SuppTableb Human Breast Yang10 112genes GeneSigDB 1.005E-5 1.510E-3 1.054E-2 6.041E-3 3 103
5 M5840 Genes up-regulated in lung relapse of breast cancer. MSigDB C2: CGP Curated Gene Sets (v6.0) 3.515E-5 4.225E-3 2.948E-2 2.113E-2 2 21
6 M1959 Genes down-regulated in primary keratinocytes by expression of p50 (NFKB1) and p65 (RELA) [GeneID=4790;5970] components of NFKB. MSigDB C2: CGP Curated Gene Sets (v6.0) 4.233E-5 4.240E-3 2.958E-2 2.544E-2 2 23
7 M2861 Genes down-regulated in epithelial lung cancer cell lines over-expressing an oncogenic form of KRAS [Gene ID=3845] gene. MSigDB C6: Oncogenic Signatures (v6.0) 6.670E-5 5.096E-3 3.555E-2 4.009E-2 3 194
8 M5126 Down-regulated genes in head and neck cancer compared to cervical carcinoma samples. MSigDB C2: CGP Curated Gene Sets (v6.0) 6.784E-5 5.096E-3 3.555E-2 4.077E-2 2 29
9 15467184-Table1a Human Stomach Lee04 37genes GeneSigDB 1.111E-4 7.417E-3
5.175E-2
6.676E-2
 2 37
10 M10702 Genes down-regulated in metastases from malignant melanoma compared to the primary tumors. MSigDB C2: CGP Curated Gene Sets (v6.0) 1.552E-4 9.328E-3
6.508E-2
9.328E-2
 3 258
11 16489042-SuppTable1a Human HeadandNeck Roepman06 396genes GeneSigDB 2.691E-4 1.313E-2
9.157E-2
1.617E-1
 3 311
12 M2700 Genes down-regulated in bone relapse of breast cancer. MSigDB C2: CGP Curated Gene Sets (v6.0) 2.768E-4 1.313E-2
9.157E-2
1.664E-1
 3 314
13 15788657-Table3 Human Ovarian Shedden05 120genes GeneSigDB 2.839E-4 1.313E-2
9.157E-2
1.706E-1
 2 59
14 M12051 Genes down-regulated in normal keratinocytes immortalized by infection with the high risk HPV31 (human papilloma virus) strain. MSigDB C2: CGP Curated Gene Sets (v6.0) 3.447E-4 1.467E-2
1.024E-1
2.071E-1
 2 65
15 16737686-Table1 Human Breast Lee06 71genes up VitD3 GeneSigDB 3.662E-4 1.467E-2
1.024E-1
2.201E-1
 2 67
16 16636340-Table2 Human Breast Smid06 87genes BoneMets GeneSigDB 5.089E-4 1.912E-2
1.334E-1
3.058E-1
 2 79
17 16353136-Table3 Human Uterine Wong05 84genes GeneSigDB 5.751E-4 2.033E-2
1.419E-1
3.457E-1
 2 84
18 M13424 Genes up-regulated in PANC-1-S4KD cells (pancreatic cancer; SMAD4 [GeneID=4089] knocked down by RNAi) after stimulation by TGF1B [GeneID=7040] for 2 h. MSigDB C2: CGP Curated Gene Sets (v6.0) 9.480E-4 3.110E-2
2.170E-1
5.697E-1
 2 108
19 M9524 Down-regulated genes that vary between HNSCC (head and neck squamous cell carcinoma) groups formed on the basis of their level of pathological differentiation: well vs moderately differentiated tumors. MSigDB C2: CGP Curated Gene Sets (v6.0) 9.832E-4 3.110E-2
2.170E-1
5.909E-1
 2 110
20 M12795 Genes up-regulated in basal-like breast cancer cell lines as compared to the mesenchymal-like ones. MSigDB C2: CGP Curated Gene Sets (v6.0) 1.188E-3 3.569E-2
2.490E-1
7.137E-1
 2 121
21 M2803 Genes down-regulated in primary keratinocytes from RB1 and RBL2 [Gene ID=5925, 5934] skin specific knockout mice. MSigDB C6: Oncogenic Signatures (v6.0) 1.562E-3 4.268E-2
2.978E-1
9.390E-1
 2 139
22 20713713-TableS1a Human Breast Taube10 160genes EMTsignature down GeneSigDB 1.562E-3 4.268E-2
2.978E-1
9.390E-1
 2 139
Show 17 more annotations

14: Coexpression Atlas [Display Chart] 10 input genes in category / 307 annotations before applied cutoff / 21829 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 esophagus esophagus Human Protein Atlas 4.286E-8 1.316E-5 8.297E-5 1.316E-5 5 247
2 Sample Type by Project: Shred 1/TCGA-Bladder/Urothelial Carcinoma/Non-Papillary Muscle Invasive Urothelial Carcinoma/3/4 Sample Type by Project: Shred 1/TCGA-Bladder/Urothelial Carcinoma/Non-Papillary Muscle Invasive Urothelial Carcinoma/3/4 TCGA-Bladder 5.783E-7 7.055E-5 4.448E-4 1.775E-4 4 161
3 Sample Type by Project: Shred 1/TCGA-Esophagus/Esophageal Carcinoma/Adenocarcinoma/6 Sample Type by Project: Shred 1/TCGA-Esophagus/Esophageal Carcinoma/Adenocarcinoma/6 TCGA-Esophagus 9.034E-7 7.055E-5 4.448E-4 2.773E-4 4 180
4 skin skin Human Protein Atlas 9.192E-7 7.055E-5 4.448E-4 2.822E-4 5 458
5 BM Top 100 - vulva BM Top 100 - vulva Body Map 6.015E-6 3.693E-4 2.329E-3 1.847E-3 3 82
6 Sample Type by Project: Shred 1/TCGA-Cervix/Cervical Carcinoma/Non-keratinizing Cervical Squamous Cell Carcinoma/4/3 Sample Type by Project: Shred 1/TCGA-Cervix/Cervical Carcinoma/Non-keratinizing Cervical Squamous Cell Carcinoma/4/3 TCGA-Cervix 8.510E-6 4.354E-4 2.746E-3 2.612E-3 3 92
7 Sample Type by Project: Shred 1/TCGA-Cervix/Cervical Carcinoma/Keratinizing Cervical Squamous Cell Carcinoma/2/0 Sample Type by Project: Shred 1/TCGA-Cervix/Cervical Carcinoma/Keratinizing Cervical Squamous Cell Carcinoma/2/0 TCGA-Cervix 2.810E-5 1.232E-3 7.771E-3 8.627E-3 3 137
8 Sample Type by Project: Shred 1/TCGA-Stomach/Stomach Adenocarcinoma/Stomach Adenocarcinoma - NOS/5/4 Sample Type by Project: Shred 1/TCGA-Stomach/Stomach Adenocarcinoma/Stomach Adenocarcinoma - NOS/5/4 TCGA-Stomach 3.468E-5 1.331E-3 8.393E-3 1.065E-2 3 147
9 PCBC ctl BronchioEpithel 500 Progenitor-Cell-Biology-Consortium reference BronchioEpithel top-relative-expression-ranked 500 PCBC 5.079E-5 1.700E-3 1.072E-2 1.559E-2 4 499
10 Sample Type by Project: Shred 1/TCGA-Breast/Breast Carcinoma/Ductal and Mucinous Carcinoma/5 Sample Type by Project: Shred 1/TCGA-Breast/Breast Carcinoma/Ductal and Mucinous Carcinoma/5 TCGA-Breast 5.539E-5 1.700E-3 1.072E-2 1.700E-2 3 172
11 Sample Type by Project: Shred 1/TCGA-Mesothelium/Mesothelioma/Epitheliod/3/2 Sample Type by Project: Shred 1/TCGA-Mesothelium/Mesothelioma/Epitheliod/3/2 TCGA-Mesothelium 2.571E-4 7.174E-3 4.524E-2
7.892E-2
 2 53
12 Arv EB-LF 2500 K3 AravindRamakr EmbryoidBody-LF top-relative-expression-ranked 2500 k-means-cluster#3 PCBC 3.865E-4 9.888E-3
6.235E-2
1.187E-1
 3 332
13 ratio SC-blastocyst vs cbCD34 500 K1 ratio StemCell-blastocyst vs cbCD34 top-relative-expression-ranked 500 k-means-cluster#1 PCBC 5.149E-4 1.129E-2
7.120E-2
1.581E-1
 2 75
14 Sample Type by Project: Shred 1/TCGA-Thryoid/Thyroid Papillary Carcinoma/Classical/4 Sample Type by Project: Shred 1/TCGA-Thryoid/Thyroid Papillary Carcinoma/Classical/4 TCGA-Thryoid 5.149E-4 1.129E-2
7.120E-2
1.581E-1
 2 75
15 BM Top 100 - nipple cross-section BM Top 100 - nipple cross-section Body Map 6.454E-4 1.221E-2
7.702E-2
1.981E-1
 2 84
16 BM Top 100 - pharyngeal mucosa BM Top 100 - pharyngeal mucosa Body Map 6.763E-4 1.221E-2
7.702E-2
2.076E-1
 2 86
17 BM Top 100 - esophagus BM Top 100 - esophagus Body Map 6.763E-4 1.221E-2
7.702E-2
2.076E-1
 2 86
18 Sample Type by Project: Shred 1/TCGA-Stomach/Stomach Adenocarcinoma/Stomach Adenocarcinoma - Diffuse/5/1 Sample Type by Project: Shred 1/TCGA-Stomach/Stomach Adenocarcinoma/Stomach Adenocarcinoma - Diffuse/5/1 TCGA-Stomach 7.241E-4 1.235E-2
7.788E-2
2.223E-1
 2 89
19 Sample Type by Project: Shred 1/TCGA-Thryoid/Thyroid Papillary Carcinoma /Follicular Sample Type by Project: Shred 1/TCGA-Thryoid/Thyroid Papillary Carcinoma /Follicular TCGA-Thryoid 8.244E-4 1.332E-2
8.400E-2
2.531E-1
 2 95
20 Arv SC-LF 2500 K3 AravindRamakr StemCell-LF top-relative-expression-ranked 2500 k-means-cluster#3 PCBC 9.435E-4 1.448E-2
9.133E-2
2.897E-1
 3 451
21 Sample Type by Project: Shred 1/TCGA-Breast/Breast Carcinoma/Infiltrating Lobular Carcinoma/3/5 Sample Type by Project: Shred 1/TCGA-Breast/Breast Carcinoma/Infiltrating Lobular Carcinoma/3/5 TCGA-Breast 1.103E-3 1.612E-2
1.017E-1
3.386E-1
 2 110
22 Sample Type by Project: Shred 1/TCGA-Esophagus/Esophageal Carcinoma/Adenocarcinoma/6/1 Sample Type by Project: Shred 1/TCGA-Esophagus/Esophageal Carcinoma/Adenocarcinoma/6/1 TCGA-Esophagus 1.332E-3 1.807E-2
1.140E-1
4.089E-1
 2 121
23 Sample Type by Project: Shred 1/TCGA-Stomach/Stomach Adenocarcinoma/Stomach Adenocarcinoma - Tubular/1/3 Sample Type by Project: Shred 1/TCGA-Stomach/Stomach Adenocarcinoma/Stomach Adenocarcinoma - Tubular/1/3 TCGA-Stomach 1.354E-3 1.807E-2
1.140E-1
4.156E-1
 2 122
24 Sample Type by Project: Shred 1/TCGA-Head and Neck/Head and Neck Carcinoma/Squamous Cell Carcinoma - Basaloid Type/3/1 Sample Type by Project: Shred 1/TCGA-Head and Neck/Head and Neck Carcinoma/Squamous Cell Carcinoma - Basaloid Type/3/1 TCGA-Head and Neck 1.827E-3 2.150E-2
1.356E-1
5.610E-1
 2 142
25 Sample Type by Project: Shred 1/TCGA-Colorectal/Colorectal Adenocarcinoma/Mucinous Colon Adenocarcinoma/4/1 Sample Type by Project: Shred 1/TCGA-Colorectal/Colorectal Adenocarcinoma/Mucinous Colon Adenocarcinoma/4/1 TCGA-Colorectal 1.904E-3 2.150E-2
1.356E-1
5.846E-1
 2 145
26 Sample Type by Project: Shred 1/TCGA-Pancreas/Pancreatic Adenocarcinoma/Colloid (Mucinous Noncystic) Carcinoma/5 Sample Type by Project: Shred 1/TCGA-Pancreas/Pancreatic Adenocarcinoma/Colloid (Mucinous Noncystic) Carcinoma/5 TCGA-Pancreas 2.009E-3 2.150E-2
1.356E-1
6.168E-1
 2 149
27 Sample Type by Project: Shred 1/TCGA-Cervix/Cervical Carcinoma/Keratinizing Cervical Squamous Cell Carcinoma/1/1 Sample Type by Project: Shred 1/TCGA-Cervix/Cervical Carcinoma/Keratinizing Cervical Squamous Cell Carcinoma/1/1 TCGA-Cervix 2.117E-3 2.150E-2
1.356E-1
6.498E-1
 2 153
28 Sample Type by Project: Shred 1/TCGA-Mesothelium/Mesothelioma/Biphasic/1/3 Sample Type by Project: Shred 1/TCGA-Mesothelium/Mesothelioma/Biphasic/1/3 TCGA-Mesothelium 2.144E-3 2.150E-2
1.356E-1
6.582E-1
 2 154
29 Sample Type by Project: Shred 1/TCGA-Pancreas/Pancreatic Adenocarcinoma/Adenocarcinoma-NOS/5/4 Sample Type by Project: Shred 1/TCGA-Pancreas/Pancreatic Adenocarcinoma/Adenocarcinoma-NOS/5/4 TCGA-Pancreas 2.172E-3 2.150E-2
1.356E-1
6.667E-1
 2 155
30 Sample Type by Project: Shred 1/TCGA-Cervix/Cervical Carcinoma/Non-keratinizing Cervical Squamous Cell Carcinoma/3/3 Sample Type by Project: Shred 1/TCGA-Cervix/Cervical Carcinoma/Non-keratinizing Cervical Squamous Cell Carcinoma/3/3 TCGA-Cervix 2.199E-3 2.150E-2
1.356E-1
6.752E-1
 2 156
31 Sample Type by Project: Shred 1/TCGA-Lung/Lung Carcinoma/Lung Squamous Cell Carcinoma/2/0 Sample Type by Project: Shred 1/TCGA-Lung/Lung Carcinoma/Lung Squamous Cell Carcinoma/2/0 TCGA-Lung 2.255E-3 2.150E-2
1.356E-1
6.923E-1
 2 158
32 Sample Type by Project: Shred 1/TCGA-Pancreas/Pancreatic Adenocarcinoma/Ductal Adenocarcinoma/5/1 Sample Type by Project: Shred 1/TCGA-Pancreas/Pancreatic Adenocarcinoma/Ductal Adenocarcinoma/5/1 TCGA-Pancreas 2.255E-3 2.150E-2
1.356E-1
6.923E-1
 2 158
33 Sample Type by Project: Shred 1/TCGA-Colorectal/Colorectal Adenocarcinoma/Rectal Adenocarcinoma/3/2 Sample Type by Project: Shred 1/TCGA-Colorectal/Colorectal Adenocarcinoma/Rectal Adenocarcinoma/3/2 TCGA-Colorectal 2.312E-3 2.150E-2
1.356E-1
7.097E-1
 2 160
34 Sample Type by Project: Shred 1/TCGA-Breast/Breast Carcinoma/Ductal and Metaplastic Carcinoma/5/1 Sample Type by Project: Shred 1/TCGA-Breast/Breast Carcinoma/Ductal and Metaplastic Carcinoma/5/1 TCGA-Breast 2.456E-3 2.206E-2
1.391E-1
7.539E-1
 2 165
35 Sample Type by Project: Shred 1/TCGA-Cervix/Cervical Carcinoma/Keratinizing Cervical Squamous Cell Carcinoma/2/5 Sample Type by Project: Shred 1/TCGA-Cervix/Cervical Carcinoma/Keratinizing Cervical Squamous Cell Carcinoma/2/5 TCGA-Cervix 2.515E-3 2.206E-2
1.391E-1
7.720E-1
 2 167
36 Sample Type by Project: Shred 1/TCGA-Lung/Lung Carcinoma/Lung Basaloid Squamous Cell Carcinoma/3/3 Sample Type by Project: Shred 1/TCGA-Lung/Lung Carcinoma/Lung Basaloid Squamous Cell Carcinoma/3/3 TCGA-Lung 2.604E-3 2.221E-2
1.400E-1
7.995E-1
 2 170
37 Sample Type by Project: Shred 1/TCGA-Breast/Breast Carcinoma/Breast Carcinoma/5 Sample Type by Project: Shred 1/TCGA-Breast/Breast Carcinoma/Breast Carcinoma/5 TCGA-Breast 2.850E-3 2.365E-2
1.491E-1
8.750E-1
 2 178
38 tonsil tonsil Human Protein Atlas 2.977E-3 2.405E-2
1.517E-1
9.140E-1
 2 182
39 ratio SC-blastocyst vs cbCD34 1000 K3 ratio StemCell-blastocyst vs cbCD34 top-relative-expression-ranked 1000 k-means-cluster#3 PCBC 4.013E-3 3.159E-2
1.992E-1
1.000E0
 2 212
40 Sample Type by Project: Shred 1/TCGA-Stomach/Stomach Adenocarcinoma/Stomach Adenocarcinoma - Mucinous/2/2 Sample Type by Project: Shred 1/TCGA-Stomach/Stomach Adenocarcinoma/Stomach Adenocarcinoma - Mucinous/2/2 TCGA-Stomach 4.116E-3 3.159E-2
1.992E-1
1.000E0
 1 9
41 BrainMap BrainAtlas - Mouse McCarroll Astrocyte.astrocytes.Rorb.Gja1 Astrocyte.astrocytes.Rorb.Gja1 Subtype Astrocyte.astrocytes.Rorb.Gja1.Myoc Top 200 Genes BrainMap BrainAtlas - Mouse McCarroll Astrocyte.astrocytes.Rorb.Gja1 Astrocyte.astrocytes.Rorb.Gja1 Subtype Astrocyte.astrocytes.Rorb.Gja1.Myoc Top 200 Genes BrainMap 5.794E-3 4.235E-2
2.671E-1
1.000E0
 2 256
42 BrainMap BrainAtlas - Mouse McCarroll Astrocyte.astrocytes.Rorb.Gja1 Astrocyte.astrocytes.Rorb.Gja1 Top 200 BrainMap BrainAtlas - Mouse McCarroll Astrocyte.astrocytes.Rorb.Gja1 Astrocyte.astrocytes.Rorb.Gja1 Top 200 BrainMap 5.794E-3 4.235E-2
2.671E-1
1.000E0
 2 256
43 gudmap developingLowerUrinaryTract adult ureter 100 k1 DevelopingLowerUrinaryTract adult ureter emap-29479 k-means-cluster#1 top-relative-expression-ranked 100 Gudmap Mouse MOE430.2 5.941E-3 4.241E-2
2.674E-1
1.000E0
 1 13
Show 38 more annotations

15: Computational [Display Chart] 6 input genes in category / 23 annotations before applied cutoff / 10037 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 M13003 MODULE 109 Serine proteases. MSigDb: C4 - CM: Cancer Modules (v6.0) 2.185E-4 5.026E-3 1.877E-2 5.026E-3 2 39

16: MicroRNA [Display Chart] 10 input genes in category / 160 annotations before applied cutoff / 72241 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 hsa-miR-6888-3p:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 1.983E-4 1.649E-2
9.327E-2
 3.173E-2 2 153
2 hsa-miR-3120-5p:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 2.061E-4 1.649E-2
9.327E-2
 3.298E-2 2 156

17: Drug [Display Chart] 10 input genes in category / 2426 annotations before applied cutoff / 22841 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 CID000010374 chlorazanil Stitch 2.121E-14 5.146E-11 4.308E-10 5.146E-11 5 16
2 CID003081658 B3852 Stitch 1.278E-13 1.550E-10 1.297E-9 3.099E-10 5 22
3 CID000072014 epanolol Stitch 2.576E-13 2.083E-10 1.744E-9 6.249E-10 5 25
4 CID000071244 SA446 Stitch 8.229E-13 4.991E-10 4.178E-9 1.996E-9 5 31
5 CID000003262 beta-estradiol 3-benzoate Stitch 5.674E-12 2.753E-9 2.305E-8 1.376E-8 6 128
6 CID006432229 CHCl Stitch 3.976E-11 1.607E-8 1.346E-7 9.645E-8 5 65
7 CID000002536 camostate Stitch 1.878E-10 6.508E-8 5.448E-7 4.555E-7 5 88
8 CID000004036 meclofenamate Stitch 2.628E-10 7.476E-8 6.259E-7 6.376E-7 5 94
9 CID005287756 AC1NRA8H Stitch 2.774E-10 7.476E-8 6.259E-7 6.729E-7 5 95
10 CID000004784 phenylmethylsulfonyl fluoride Stitch 4.448E-10 1.079E-7 9.034E-7 1.079E-6 6 263
11 CID000003910 Leupeptin hydrochloride Stitch 5.946E-10 1.307E-7 1.094E-6 1.442E-6 6 276
12 CID003083715 angiotensin Stitch 6.767E-10 1.307E-7 1.094E-6 1.642E-6 6 282
13 CID000004495 nimesulide Stitch 7.003E-10 1.307E-7 1.094E-6 1.699E-6 5 114
14 CID000002249 atenolol Stitch 9.874E-10 1.711E-7 1.432E-6 2.395E-6 5 122
15 CID000002162 amlodipine Stitch 1.162E-9 1.763E-7 1.476E-6 2.820E-6 5 126
16 CID000003222 CAS 76095-16-4 Stitch 1.162E-9 1.763E-7 1.476E-6 2.820E-6 5 126
17 CID000036095 dibutyryl cyclic GMP Stitch 1.361E-9 1.943E-7 1.626E-6 3.303E-6 5 130
18 CID000005936 diisopropylfluorophosphate Stitch 1.473E-9 1.985E-7 1.662E-6 3.573E-6 6 321
19 CID000000564 EACA Stitch 2.899E-9 3.702E-7 3.099E-6 7.033E-6 5 151
20 CID000006026 kinin 9 Stitch 3.077E-9 3.733E-7 3.125E-6 7.466E-6 6 363
21 CID000004427 TLCK Stitch 3.642E-9 4.208E-7 3.523E-6 8.837E-6 5 158
22 CID000072363 L-lysyl-L-lysyl-L-lysine Stitch 4.131E-9 4.555E-7 3.814E-6 1.002E-5 5 162
23 CID000086322 CP094 Stitch 4.531E-9 4.779E-7 4.001E-6 1.099E-5 5 165
24 CID000003907 LTC4 (leukotriene C4 Stitch 7.017E-9 7.001E-7 5.861E-6 1.702E-5 5 180
25 CID000002866 amsonine Stitch 7.215E-9 7.001E-7 5.861E-6 1.750E-5 5 181
26 CID000000180 acetone Stitch 8.499E-9 7.930E-7 6.638E-6 2.062E-5 5 187
27 CID000002550 H526 Stitch 9.702E-9 8.717E-7 7.298E-6 2.354E-5 5 192
28 CID000002471 bumetanide Stitch 1.485E-8 1.286E-6 1.077E-5 3.602E-5 5 209
29 CID000005267 AC1Q6PCP Stitch 2.397E-8 1.981E-6 1.659E-5 5.816E-5 5 230
30 CID000001123 taurine Stitch 2.450E-8 1.981E-6 1.659E-5 5.944E-5 5 231
31 CID000086345 Cp51 Stitch 2.742E-8 2.146E-6 1.796E-5 6.652E-5 3 15
32 CID000002803 clonidine Stitch 2.966E-8 2.226E-6 1.864E-5 7.195E-5 5 240
33 CID000002153 theophylline Stitch 3.028E-8 2.226E-6 1.864E-5 7.347E-5 5 241
34 CID000003440 furosemide Stitch 5.541E-8 3.953E-6 3.310E-5 1.344E-4 5 272
35 CID000040973 desogestrel Stitch 9.006E-8 6.242E-6 5.226E-5 2.185E-4 4 106
36 CID000000853 thryroxine Stitch 9.331E-8 6.288E-6 5.264E-5 2.264E-4 5 302
37 CID000028112 lithium aluminum hydride Stitch 1.245E-7 8.161E-6 6.832E-5 3.019E-4 5 320
38 CID000000187 acetylcholine Stitch 2.265E-7 1.439E-5 1.205E-4 5.495E-4 5 361
39 CID000015184 Proresid Stitch 2.314E-7 1.439E-5 1.205E-4 5.614E-4 4 134
40 CID011979316 vasopressin Stitch 3.239E-7 1.964E-5 1.644E-4 7.858E-4 5 388
41 CID000002332 benzamidine Stitch 3.356E-7 1.986E-5 1.662E-4 8.141E-4 4 147
42 CID000126484 FFRck Stitch 3.590E-7 2.047E-5 1.714E-4 8.710E-4 3 34
43 CID000005839 aldosterone Stitch 3.628E-7 2.047E-5 1.714E-4 8.803E-4 5 397
44 CID000002909 cyclophorine Stitch 5.203E-7 2.869E-5 2.402E-4 1.262E-3 5 427
45 CID000122333 S2266 Stitch 5.920E-7 3.191E-5 2.672E-4 1.436E-3 3 40
46 CID005459389 DB04780 Stitch 6.149E-7 3.243E-5 2.715E-4 1.492E-3 4 171
47 CID000123643 T-kinin Stitch 6.386E-7 3.261E-5 2.730E-4 1.549E-3 3 41
48 CID000000838 L-adrenaline Stitch 6.452E-7 3.261E-5 2.730E-4 1.565E-3 5 446
49 CID000005410 NSC98537 Stitch 8.625E-7 4.270E-5 3.575E-4 2.092E-3 5 473
50 CID000097369 N-benzoyl-L-arginine Stitch 1.841E-6 8.933E-5 7.478E-4 4.467E-3 3 58
Show 45 more annotations

18: Disease [Display Chart] 10 input genes in category / 140 annotations before applied cutoff / 16205 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 C0265962 Ichthyosis linearis circumflexa DisGeNET Curated 1.003E-6 1.404E-4 7.751E-4 1.404E-4 3 34
2 C0011606 Exfoliative dermatitis DisGeNET Curated 2.017E-4 1.234E-2
6.816E-2
 2.824E-2 2 35
3 C0276638 Pseudoscarlatina DisGeNET BeFree 6.171E-4 1.234E-2
6.816E-2
8.639E-2
 1 1
4 C0600336 Subcorneal pustular dermatosis DisGeNET BeFree 6.171E-4 1.234E-2
6.816E-2
8.639E-2
 1 1
5 OMIN:256500 NETHERTON SYNDROME; NETH OMIM 6.171E-4 1.234E-2
6.816E-2
8.639E-2
 1 1
6 cv:C0265962 Netherton syndrome Clinical Variations 6.171E-4 1.234E-2
6.816E-2
8.639E-2
 1 1
7 C1274167 IgA pemphigus DisGeNET BeFree 6.171E-4 1.234E-2
6.816E-2
8.639E-2
 1 1
8 C0040580 Tracheal Diseases DisGeNET BeFree 8.799E-4 1.439E-2
7.949E-2
1.232E-1
 2 73
9 C0432347 Uncombable hair syndrome DisGeNET Curated 1.234E-3 1.439E-2
7.949E-2
1.727E-1
 1 2
10 C1860607 Uncombable hair DisGeNET Curated 1.234E-3 1.439E-2
7.949E-2
1.727E-1
 1 2
11 C4020850 Generalized trichodysplasia DisGeNET Curated 1.234E-3 1.439E-2
7.949E-2
1.727E-1
 1 2
12 C0011302 Demyelinating disease of central nervous system DisGeNET BeFree 1.234E-3 1.439E-2
7.949E-2
1.727E-1
 1 2
13 C0037274 Dermatologic disorders DisGeNET Curated 1.496E-3 1.524E-2
8.415E-2
2.095E-1
 3 393
14 C0011615 Dermatitis, Atopic DisGeNET Curated 1.702E-3 1.524E-2
8.415E-2
2.383E-1
 3 411
15 C1704272 Benign Prostatic Hyperplasia DisGeNET BeFree 1.738E-3 1.524E-2
8.415E-2
2.433E-1
 3 414
16 C4025700 Trichodysplasia DisGeNET Curated 1.850E-3 1.524E-2
8.415E-2
2.590E-1
 1 3
17 C1850544 Hypernatremic dehydration DisGeNET Curated 1.850E-3 1.524E-2
8.415E-2
2.590E-1
 1 3
18 C0013595 Eczema DisGeNET Curated 2.043E-3 1.569E-2
8.667E-2
2.860E-1
 3 438
19 C0033774 Pruritus DisGeNET Curated 2.315E-3 1.569E-2
8.667E-2
3.242E-1
 2 119
20 C0263485 Clastothrix DisGeNET Curated 2.466E-3 1.569E-2
8.667E-2
3.453E-1
 1 4
21 C1860608 Pili canaliculi DisGeNET Curated 2.466E-3 1.569E-2
8.667E-2
3.453E-1
 1 4
22 C0019112 Hemorrhoids DisGeNET Curated 2.466E-3 1.569E-2
8.667E-2
3.453E-1
 1 4
23 C2931852 Clear-cell metastatic renal cell carcinoma DisGeNET Curated 3.098E-3 1.886E-2
1.041E-1
4.337E-1
 2 138
24 C0038165 Staphylococcal Scalded Skin Syndrome DisGeNET BeFree 3.697E-3 2.156E-2
1.191E-1
5.176E-1
 1 6
25 C0239816 Hand eczema DisGeNET BeFree 4.312E-3 2.156E-2
1.191E-1
6.037E-1
 1 7
26 C0239804 White hair DisGeNET Curated 4.312E-3 2.156E-2
1.191E-1
6.037E-1
 1 7
27 C0851886 Pneumocystis Infections DisGeNET BeFree 4.312E-3 2.156E-2
1.191E-1
6.037E-1
 1 7
28 C1836607 MYOTILINOPATHY DisGeNET Curated 4.312E-3 2.156E-2
1.191E-1
6.037E-1
 1 7
29 OMIN:147050 IgE RESPONSIVENESS, ATOPIC; IGER OMIM 4.927E-3 2.210E-2
1.220E-1
6.898E-1
 1 8
30 cv:C1840253 Ige responsiveness, atopic Clinical Variations 4.927E-3 2.210E-2
1.220E-1
6.898E-1
 1 8
31 C1840253 IgE RESPONSIVENESS, ATOPIC DisGeNET Curated 4.927E-3 2.210E-2
1.220E-1
6.898E-1
 1 8
32 C1319315 Adenocarcinoma of large intestine DisGeNET BeFree 5.095E-3 2.210E-2
1.220E-1
7.133E-1
 2 178
33 C2609259 Symphysis Pubis Dysfunction DisGeNET BeFree 5.542E-3 2.210E-2
1.220E-1
7.758E-1
 1 9
34 C0152426 Craniorachischisis DisGeNET Curated 5.542E-3 2.210E-2
1.220E-1
7.758E-1
 1 9
35 C0243010 Viral Encephalitis DisGeNET BeFree 5.542E-3 2.210E-2
1.220E-1
7.758E-1
 1 9
36 C1334407 Localized Carcinoma DisGeNET BeFree 6.156E-3 2.210E-2
1.220E-1
8.618E-1
 1 10
37 C0236175 Elevated IgE DisGeNET Curated 6.156E-3 2.210E-2
1.220E-1
8.618E-1
 1 10
38 C0002994 Angioedema DisGeNET Curated 6.156E-3 2.210E-2
1.220E-1
8.618E-1
 1 10
39 C0796563 Localized Malignant Neoplasm DisGeNET BeFree 6.156E-3 2.210E-2
1.220E-1
8.618E-1
 1 10
40 C0040425 Tonsillitis DisGeNET BeFree 7.383E-3 2.584E-2
1.427E-1
1.000E0
 1 12
41 C4072835 Kinky hair texture DisGeNET Curated 7.996E-3 2.603E-2
1.438E-1
1.000E0
 1 13
42 C4073292 Afro-textured hair DisGeNET Curated 7.996E-3 2.603E-2
1.438E-1
1.000E0
 1 13
43 C4072836 Nappy hair texture DisGeNET Curated 7.996E-3 2.603E-2
1.438E-1
1.000E0
 1 13
44 C1863051 ALZHEIMER DISEASE 2 DisGeNET Curated 8.608E-3 2.699E-2
1.491E-1
1.000E0
 1 14
45 C1859541 Variable degree of villous atrophy DisGeNET Curated 9.832E-3 2.699E-2
1.491E-1
1.000E0
 1 16
46 C0554101 Villous atrophy DisGeNET Curated 9.832E-3 2.699E-2
1.491E-1
1.000E0
 1 16
47 C2677378 Duodenal villous atrophy DisGeNET Curated 9.832E-3 2.699E-2
1.491E-1
1.000E0
 1 16
48 C1833058 Small intestine biopsy shows villous atrophy DisGeNET Curated 9.832E-3 2.699E-2
1.491E-1
1.000E0
 1 16
49 C4020747 Biopsy shows villous atrophy DisGeNET Curated 9.832E-3 2.699E-2
1.491E-1
1.000E0
 1 16
50 C4021745 Abnormality of the musculature DisGeNET Curated 9.832E-3 2.699E-2
1.491E-1
1.000E0
 1 16
Show 45 more annotations